Thomas Steyer’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,000
Closed -$290K 116
2026
Q1
$290K Sell
3,000
-231,500
-99% -$23.7M ﹤0.01% 123
2025
Q4
$24.9M Sell
234,500
-336,500
-59% -$39M 0.11% 68
2025
Q3
$72.5M Sell
571,000
-137,000
-19% -$16.3M 0.3% 50
2025
Q2
$86.8M Buy
708,000
+89,000
+14% +$10.2M 0.36% 47
2025
Q1
$62.7M Buy
619,000
+158,000
+34% +$15.4M 0.3% 51
2024
Q4
$42.6M Buy
461,000
+458,000
+15,267% +$45M 0.19% 62
2024
Q3
$290K Hold
3,000
﹤0.01% 123
2024
Q2
$257K Hold
3,000
﹤0.01% 122
2024
Q1
$248K Hold
3,000
﹤0.01% 135
2023
Q4
$200K Hold
3,000
﹤0.01% 131
2023
Q3
$201K Sell
3,000
-97,000
-97% -$6.67M ﹤0.01% 129
2023
Q2
$6.77M Buy
+100,000
New +$6.27M 0.03% 98

Other funds holding EHC

Thomas Steyer's EHC Position: Q2 2026 in Review

Thomas Steyer sold out of Encompass Health (EHC) in Q2 2026, closing a stake of 3,000 shares — an estimated $290K sold.

Thomas Steyer first reported a position in EHC in Q2 2023 and held it in 12 quarters. The position peaked at $86.8M in Q2 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Thomas Steyer reported no remaining Encompass Health position as of Q2 2026 after selling out during the quarter.
  • Thomas Steyer sold 3,000 Encompass Health shares in Q2 2026, an estimated $290K.
  • Thomas Steyer first reported a position in Encompass Health in Q2 2023 and held it in 12 quarters.
  • Thomas Steyer's Encompass Health position peaked at $86.8M in Q2 2025.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.